10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2017 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 14, 2018) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Net revenues | $ 184,765 | 177,526 | 153,290 |
| Cost of revenues | 156,220 | 148,669 | 126,762 |
| Gross profit | 28,545 | 28,857 | 26,528 |
| Operating expenses | 19,028 | 18,491 | 17,053 |
| Operating profit | 9,517 | 10,366 | 9,475 |
| Interest expense, net | 1,041 | 1,058 | 838 |
| Loss on early extinguishment of debt | 643 | 0 | |
| Other expense | 208 | 28 | 21 |
| Income before income tax provision | 8,268 | 8,637 | 8,616 |
| Income tax provision | 1,637 | 3,317 | 3,386 |
| Income from continuing operations | 6,631 | 5,320 | 5,230 |
| Income (loss) from discontinued operations, net of tax | (8) | (1) | 9 |
| Net income | 6,623 | 5,319 | 5,239 |
| Net income attributable to noncontrolling interest | (1) | (2) | (2) |
| Net income attributable to CVS Health | 6,622 | 5,317 | 5,237 |
| Basic earnings per share: | |||
| Income from continuing operations attributable to CVS Health (in dollars per share) | 6.48 | 4.93 | 4.65 |
| Income (loss) from discontinued operations attributable to CVS Health (in dollars per share) | (0.01) | 0.01 | |
| Net income attributable to CVS Health (in dollars per share) | 6.47 | 4.93 | 4.66 |
| Weighted average shares outstanding (in shares) | 1,020 | 1,073 | 1,118 |
| Diluted earnings per share: | |||
| Income from continuing operations attributable to CVS Health (in dollars per share) | 6.45 | 4.91 | 4.62 |
| income (loss) from discontinued operations attributable to CVS Health (in dollars per share) | (0.01) | 0.01 | |
| Net income attributable to CVS Health (in dollars per share) | 6.44 | 4.90 | 4.63 |
| Weighted average shares outstanding (in shares) | 1,024 | 1,079 | 1,126 |
| Dividends declared per share (in dollars per share) | 2.00 | 1.70 | 1.40 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2017 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 14, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Net income | $ 6,623 | 5,319 | 5,239 |
| Other comprehensive income: | |||
| Foreign currency translation adjustments, net of tax | (2) | 38 | (100) |
| Net cash flow hedges, net of tax | (10) | 2 | 2 |
| Pension and other postretirement benefits, net of tax | 152 | 13 | (43) |
| Total other comprehensive income (loss) | 140 | 53 | (141) |
| Comprehensive income | 6,763 | 5,372 | 5,098 |
| Comprehensive income attributable to noncontrolling interest | (1) | (2) | (2) |
| Comprehensive income attributable to CVS Health | 6,762 | 5,370 | 5,096 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2017 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2017 10-K (Filed: Feb 14, 2018) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 176,594 | 172,310 | 148,954 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (149,279) | (142,511) | (122,498) |
| Cash paid to other suppliers and employees | (15,348) | (15,478) | (14,035) |
| Interest received | 21 | 20 | 21 |
| Interest paid | (1,072) | (1,140) | (629) |
| Income taxes paid | (2,909) | (3,060) | (3,274) |
| Net cash provided by operating activities | 8,007 | 10,141 | 8,539 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (1,918) | (2,224) | (2,367) |
| Proceeds from sale-leaseback transactions | 265 | 230 | 411 |
| Proceeds from sale of property and equipment and other assets | 33 | 37 | 35 |
| Acquisitions (net of cash acquired) and other investments | (1,287) | (539) | (11,475) |
| Purchase of available-for-sale investments | (86) | (65) | (267) |
| Maturity of available-for-sale investments | 61 | 91 | 243 |
| Net cash used in investing activities | (2,932) | (2,470) | (13,420) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (598) | 1,874 | (685) |
| Proceeds from issuance of long-term debt | 3,455 | 14,805 | |
| Repayments of long-term debt | (5,943) | (2,902) | |
| Purchase of noncontrolling interest in subsidiary | (39) | ||
| Payment of contingent consideration | (26) | (58) | |
| Dividends paid | (2,049) | (1,840) | (1,576) |
| Proceeds from exercise of stock options | 329 | 296 | 362 |
| Payments for taxes related to net share settlement of equity awards | (71) | (72) | (63) |
| Repurchase of common stock | (4,361) | (4,461) | (5,001) |
| Other | (1) | (5) | (3) |
| Net cash provided by (used in) financing activities | (6,751) | (6,761) | 4,879 |
| Effect of exchange rate changes on cash and cash equivalents | 1 | 2 | (20) |
| Net increase (decrease) in cash and cash equivalents | (1,675) | 912 | (22) |
| Cash and cash equivalents at the beginning of the period | 3,371 | 2,459 | |
| Cash and cash equivalents at the end of the period | 1,696 | 3,371 | 2,459 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 6,623 | 5,319 | 5,239 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 2,479 | 2,475 | 2,092 |
| Goodwill impairment | 181 | ||
| Losses on settlement of defined benefit pension plans | 187 | ||
| Stock-based compensation | 234 | 222 | 230 |
| Loss on early extinguishment of debt | 643 | 0 | |
| Deferred income taxes | (1,334) | 18 | (252) |
| Other noncash items | 53 | 135 | (14) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (941) | (243) | (1,594) |
| Inventories | (514) | (742) | (1,141) |
| Other current assets | (341) | 35 | 355 |
| Other assets | 3 | (43) | 2 |
| Accounts payable and claims and discounts payable | 1,710 | 2,189 | 2,834 |
| Accrued expenses | (371) | 131 | 892 |
| Other long-term liabilities | 38 | 2 | (104) |
| Net cash provided by operating activities | 8,007 | 10,141 | 8,539 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2017 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2017 10-K (Filed: Feb 14, 2018) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2017 | Dec 31, 2016 | |
| Assets: | ||
| Cash and cash equivalents | $ 1,696 | 3,371 |
| Short-term investments | 111 | 87 |
| Accounts receivable, net | 13,181 | 12,164 |
| Inventories | 15,296 | 14,760 |
| Other current assets | 945 | 660 |
| Total current assets | 31,229 | 31,042 |
| Property and equipment, net | 10,292 | 10,175 |
| Goodwill | 38,451 | 38,249 |
| Intangible assets, net | 13,630 | 13,511 |
| Other assets | 1,529 | 1,485 |
| Total assets | 95,131 | 94,462 |
| Liabilities: | ||
| Accounts payable | 8,863 | 7,946 |
| Claims and discounts payable | 10,355 | 9,451 |
| Accrued expenses | 6,609 | 6,937 |
| Short-term debt | 1,276 | 1,874 |
| Current portion of long-term debt | 3,545 | 42 |
| Total current liabilities | 30,648 | 26,250 |
| Long-term debt | 22,181 | 25,615 |
| Deferred income taxes | 2,996 | 4,214 |
| Other long-term liabilities | 1,611 | 1,549 |
| Shareholders' equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | ||
| Common stock, par value $0.01: 3,200 shares authorized; 1,712 shares issued and 1,014 shares outstanding at December 31, 2017 and 1,705 shares issued and 1,061 shares outstanding at December 31, 2016 | 17 | 17 |
| Treasury stock, at cost: 697 shares at December 31, 2017 and 643 shares at December 31, 2016 | (37,765) | (33,452) |
| Shares held in trust: 1 share at December 31, 2017 and December 31, 2016 | (31) | (31) |
| Capital surplus | 32,079 | 31,618 |
| Retained earnings | 43,556 | 38,983 |
| Accumulated other comprehensive income (loss) | (165) | (305) |
| Total CVS Health shareholders' equity | 37,691 | 36,830 |
| Noncontrolling interest | 4 | 4 |
| Total shareholders' equity | 37,695 | 36,834 |
| Total liabilities and shareholders' equity | 95,131 | 94,462 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2017 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |